# Evaluation of 4 Artemisinin-based Combinations for Treating Uncomplicated Malaria in African Children

> **NCT00393679** · PHASE3 · COMPLETED · sponsor: **Institute of Tropical Medicine, Belgium** · enrollment: 4112 (actual)

## Conditions studied

- Fever
- Malaria

## Interventions

- **DRUG:** amodiaquine-artesunate (ASAQ)
- **DRUG:** dihydroartemisinin-piperaquine (DHAPQ)
- **DRUG:** artemether-lumefantrine (AL)
- **DRUG:** Lapdap (Chlorproguanil-Dapsone) + artesunate (AS)

## Key facts

- **NCT ID:** NCT00393679
- **Lead sponsor:** Institute of Tropical Medicine, Belgium
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 4112 (ACTUAL)
- **Last updated:** 2014-02-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00393679

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00393679, "Evaluation of 4 Artemisinin-based Combinations for Treating Uncomplicated Malaria in African Children". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00393679. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*